BACKGROUND: Abdominal pain is a debilitating symptom in patients with inflammatory bowel disease. Previously we have shown that cannabinoid 1 receptor (CB1R) agonists are less effective at inhibiting abdominal pain in mice with acute colitis compared to healthy mice…